Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: Post hoc analysis of a randomized placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 76, Issue 4, 2015, Pages 398-405

  McIntyre, Roger S ^a,b   Cucchiaro, Josephine ^c   Pikalov, Andrei ^c   Kroger, Hans ^c   Loebel, Antony ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LURASIDONE; PLACEBO; ISOINDOLE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; AGED; AKATHISIA; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DSM-IV-TR; FEMALE; GOOD CLINICAL PRACTICE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MIXED SUBSYNDROMAL HYPOMANIC SYMPTOM; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SOMNOLENCE; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; CLASSIFICATION; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; DOSE RESPONSE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOINDOLES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; THIAZOLES;

EID: 84932155059     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.14m09410     Document Type: Article

References (27)

1. Vieta E, Valentí M. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord. 2013;148(1):28-36. doi:10.1016/j.jad.2013.03.07 PubMed
2. Swann AC, Lafer B, Perugi G, et al. Bipolar mixed states: an International Society for Bipolar Disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry. 2013;170(1):31-42. doi:10.176/api.ajp.2012.12030301 PubMed
3. Zimmermann P, Brückl T, Nocon A, et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry. 2009;66(12):1341-1352. doi:10.101/archgenpsychiatry.209.158 PubMed
4. Azorin JM, Kaladjian A, Adida M, et al. Self-assessment and characteristics of mixed depression in the French national EPIDEP study. J Affect Disord. 2012;143(1-3):109-117. doi:10.1016/j.jad.2012.05.036 PubMed
5. Goldberg JF, Perlis RH, Bowden CL, et al. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009;166(2):173-181. doi:10.176/api.ajp.208.08050746 PubMed
6. Frye MA, Helleman G, McElroy SL, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009;166(2):164-172. doi:10.176/api.ajp.208.0803032 PubMed
7. Benazzi F. Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states). Eur Psychiatry. 2008;23(1):40-48. doi:10.1016/j.eurpsy.207.07.03 PubMed
8. Benazzi F, Akiskal HS. Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: The relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J Affect Disord. 2001;67(1-3):115-122. doi:10.1016/S0165-0327(01)04-X PubMed
9. Nusslock R, Frank E. Subthreshold bipolarity: diagnostic issues and challenges. Bipolar Disord. 2011;13(7-8):587-603. doi:10.1/j.139-5618.201.0957.x PubMed
10. McIntyre RS, Soczynska JK, Cha DS, et al. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project. J Affect Disord. 2014;172C:259-264. PubMed
11. Tohen M, Kanba S, McIntyre RS, et al. Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features. J Affect Disord. 2014;164:57-62. doi:10.1016/j.jad.2014.04.03 PubMed
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Publishing, 2000.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Publishing; 2013.
14. Loebel A, Cucchiaro J, Silva R, et al. Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebocontrolled study. Am J Psychiatry. 2014;171(2):160-168. doi:10.176/api.ajp.2013.13070984 PubMed
15. Loebel A, Cucchiaro J, Silva R, et al. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2014;171(2):169-177. doi:10.176/api.ajp.2013.13070985 PubMed
16. Citrome L, Ketter TA, Cucchiaro J, et al. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. J Affect Disord. 2014;155:20-27. doi:10.1016/j.jad.2013.10.040 PubMed
17. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.192/bjp.134.4.382 PubMed
18. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429-435. doi:10.192/bjp.13.5.429 PubMed
19. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res. 1997;73(3):159-171. doi:10.1016/S0165-1781(97)0123-6 PubMed
20. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and selfreport (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. doi:10.1016/S06-323(02)0186-8 PubMed
21. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55. doi:10.1/j.204-8341.1959.tb0467.x PubMed
22. Sheehan DV. The Anxiety Disease. New York, NY: Bantam Books; 1983.
23. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacol Bull. 1993;29(2):321-326. PubMed
24. Chappell P, Feltner DE, Makumi C, et al. Initial validity and reliability data on the Columbia-Suicide Severity Rating Scale. Am J Psychiatry. 2012;169(6):662-663, author reply 663. doi:10.176/api.ajp.2012.12010123 PubMed
25. Version SAS. 9.2 [computer program]. Cary, NC: SAS Institute Inc; 2008.
26. Cassidy F, Yatham LN, Berk M, et al. Pure and mixed manic subtypes: A review of diagnostic classification and validation. Bipolar Disord. 2008;10 (1, pt 2):131-143. doi:10.1/j.139-5618.207.058.x PubMed
27. Benazzi F, Berk M, Frye MA, et al. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: A post hoc analysis. J Clin Psychiatry. 2009;70(10):1424-1431. doi:10.408/JCP.08m0472gre PubMed